Makers Laboratories Ltd.

About

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, antiinflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company also exports its products. Makers Laboratories Limited was incorporated in 1984 and is based in Mumbai, India.

Key Metrics

as of Sep 2026

Market Cap113 Cr

P/E33.00

Div Yield0.00 %

Book Value₹124.00

52w High₹237.00

52w Low₹109.00

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	42.77	35.75	35.67	34.17	35.00	33.90	27.69	29.57	29.59	27.81	26.51	25.06	25.01
Expenses	35.81	30.47	31.51	31.89	31.99	30.81	26.38	27.38	27.78	26.95	26.31	24.86	25.15
Operating Profit	6.96	5.28	4.16	2.28	3.01	3.09	1.31	2.19	1.81	0.86	0.20	0.20	-0.14
OPM %	16.27	14.77	11.66	6.67	8.60	9.12	4.73	7.41	6.12	3.09	0.75	0.80	-0.56
Other Income	0.61	0.76	0.33	0.36	0.27	0.10	0.87	10.63	-0.51	0.43	0.37	0.41	0.25
Depreciation	1.13	1.13	1.14	1.13	1.12	0.90	1.31	1.29	1.28	1.15	1.16	1.13	1.11
Interest	0.15	0.17	0.20	0.22	0.18	0.18	0.19	0.43	0.49	0.52	0.53	0.49	0.41
Profit before tax	6.29	4.74	3.15	1.29	1.98	2.11	0.68	11.10	-0.47	-0.38	-1.12	-1.01	-1.41
Tax %	27.03	24.89	27.94	42.64	34.85	24.64	60.29	11.98	48.94	152.63	-4.46	10.89	18.44
Net Profit	4.59	3.56	2.27	0.74	1.29	1.58	0.27	9.76	-0.70	-0.97	-1.06	-1.13	-1.66
EPS in Rs	2.54	1.85	1.59	-0.20	0.75	-0.08	-0.51	14.95	-1.66	-2.19	-2.61	-2.27	-3.56

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Sales	141.00	121.00	104.00	101.00	127.00	69.00
Expenses	126.00	112.00	103.00	98.00	108.00	60.00
Operating Profit	15.00	9.00	1.00	3.00	19.00	8.00
OPM %	11.00	7.00	1.10	3.30	15.00	12.00
Other Income	2.00	11.00	2.00	2.00	3.00	1.00
Interest	1.00	1.00	2.00	2.00	2.00	2.00
Depreciation	5.00	5.00	5.00	4.00	4.00	5.00
Profit before tax	11.00	13.00	-4.00	-1.00	16.00	3.00
Tax %	30.00	19.00	23.00	161.00	25.00	50.00
Net Profit	8.00	11.00	-5.00	-2.00	12.00	1.00
EPS in Rs	3.98	12.69	-10.61	-8.05	8.44	-0.56
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Equity Capital	6.00	6.00	6.00	6.00	5.00	5.00
Reserves	67.00	65.00	57.00	63.00	55.00	49.00
Borrowings	9.00	8.00	22.00	17.00	23.00	21.00
Other Liabilities	85.00	70.00	76.00	66.00	62.00	62.00
Total Liabilities	167.00	148.00	161.00	152.00	144.00	136.00
Fixed Assets	71.00	74.00	87.00	85.00	68.00	71.00
CWIP	4.00	1.00	0.00	0.00	9.00	0.00
Investments	12.00	0.00	3.00	0.00	0.00	2.00
Other Assets	81.00	73.00	71.00	67.00	66.00	63.00
Total Assets	167.00	148.00	161.00	152.00	144.00	136.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	14.00	-4.00	1.00	-9.00	18.00
Cash from Investing Activity	-15.00	20.00	-7.00	1.00	-22.00
Cash from Financing Activity	0.00	-16.00	6.00	6.00	0.00
Net Cash Flow	0.00	0.00	0.00	-2.00	-3.00
Free Cash Flow	11.00	11.00	-6.00	-21.00	9.00
CFO/OP %	118.00	-20.00	232.00	-185.00	128.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Debtor Days	52.00	85.00	70.00	72.00	39.00	88.00
Inventory Days	250.00	230.00	227.00	281.00	166.00	344.00
Days Payable	110.00	79.00	112.00	91.00	38.00	182.00
Cash Conversion Cycle	192.00	236.00	185.00	262.00	167.00	250.00
Working Capital Days	106.00	140.00	97.00	113.00	61.00	112.00
ROCE %	9.00	4.00	-2.00	1.00	15.00	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	61.28	61.28	61.28	61.28	61.28	61.28	61.28	61.28	61.28	61.28	61.28	61.28
DIIs	0.39	0.39	0.39	0.39	0.39	0.39	0.39	0.00	0.00	0.00	0.00	0.00
Public	38.34	38.34	38.35	38.35	38.35	38.34	38.33	38.73	38.74	38.73	38.74	38.73
No. of Shareholders	3,745	3,801	3,926	4,026	4,073	4,135	4,031	4,008	4,090	4,176	4,179	4,283

Corporate Actions

8 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Other	30 Mar 2022	01 Apr 2022	—	—	Right Issue of Equity Shares
Dividend	01 Aug 2019	—	—	1.00
Dividend	26 Jul 2018	—	—	1.00
Dividend	20 Jul 2017	—	—	1.00
Dividend	02 Aug 2016	—	—	1.00
Dividend	28 Jul 2015	—	—	1.00
Dividend	29 Jul 2011	—	—	1.00
Dividend	17 Aug 2010	—	—	1.00